WHO Declares Ebola Outbreak a Global Health Emergency
Chia-Yi Hou | Jul 18, 2019
The current outbreak in Democratic Republic of Congo has been going on for nearly a year, and the new status could bring in more funding and assistance.
EPA Will Not Ban Pesticide Linked to Neurological Issues
EPA Will Not Ban Pesticide Linked to Neurological Issues
The agency argues that chlorpyrifos is one of few “cost-effective options” for controlling certain farm pests.
The agency argues that chlorpyrifos is one of few “cost-effective options” for controlling certain farm pests.
Measles Kills Thousands in Democratic Republic of Congo
Shawna Williams | Jul 16, 2019
Deaths attributed to the disease have outpaced those from Ebola this year.
Experimental Ebola Treatments Approved for Use in Uganda
Catherine Offord | Jun 19, 2019
The announcement comes as the country prepares for possible spread of the virus from Democratic Republic of Congo.
Isolated Ebola Cases Hard to Diagnose, Go Undetected
Munyaradzi Makoni | Jun 18, 2019
Wide availability of infection control and diagnostic resources is required to control outbreaks early.
Three Ebola Cases Identified in Uganda
Kerry Grens | Jun 12, 2019
The cases, which spread from the outbreak in the DRC, include a five-year-old boy who died.
Measles to Hit Chicago, Los Angeles, and Miami Next, Study Predicts
Ashley P. Taylor | May 13, 2019
The forecast for upcoming outbreaks failed to foresee the cluster of infections currently affecting Brooklyn.
A New Fund Pledges to Help Scientists in Africa Start Their Own Labs
Munyaradzi Makoni | Apr 26, 2019
A lack of resources ordinarily blocks young researchers on the continent from scholarly independence, but long-term support is no guarantee.
US Measles Cases Break Record Since Returning to Country
Catherine Offord | Apr 25, 2019
There are now more cases of measles in America than in any year since the disease was eradicated nearly 20 years ago.
Tuberculosis Can Emerge After Cancer Immunotherapy
Ashley Yeager | Apr 1, 2019
At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.